Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125499182 | 12549918 | 2 | F | 20160711 | 20160712 | 20160718 | EXP | US-TEVA-676142USA | TEVA | CAROWAY M, SCOTT J, THAKAR CV. MECHANISMS OF RHABDOMYOLYSIS INDUCED AKI IN THE INTENSIVE CARE UNIT: A CASE SERIES.AMERICAN JOURNAL OF KIDNEY DISEASES. 2016; 67(5):A31 | 80.00 | YR | M | Y | 0.00000 | 20160718 | MD | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125499182 | 12549918 | 1 | PS | CLARITHROMYCIN. | CLARITHROMYCIN | 1 | Y | 65154 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125499182 | 12549918 | 1 | Helicobacter infection |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125499182 | 12549918 | HO |
125499182 | 12549918 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125499182 | 12549918 | Acute kidney injury | |
125499182 | 12549918 | Drug interaction | |
125499182 | 12549918 | Rhabdomyolysis |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |